Descriptive epidemiology of soft tissue and bone sarcomas in Lebanon. Issue 3 (March 2022)

• Record Type: Journal Article
• Authors: Bou Zerdan, Maroun; Meouchy, Paul; Abdul Halim, Nour; Saghieh, Said; Sbaity, Eman; Haidar, Rachid; Abbas, Jaber; Ibrahim, Amir; Khalifeh, Mohamad; Assi, Hazem I
• Is Part Of: Journal of international medical research. Volume 50:Issue 3(2022)
• Publication Date: 2022-03
• Subjects: Soft tissue sarcoma -- leiomyosarcoma -- dermatofibrosarcoma -- liposarcoma -- rhabdomyosarcoma -- angiosarcoma -- malignant fibrous histiocytoma; Medicine -- Periodicals; Pharmacology -- Periodicals; 610.5
• DOI: 10.1177/03000605221082852
• Languages: English
• ISSNs: 0300-0605

Abstract

Objectives: Most epidemiologic studies on soft tissue sarcomas (STS) and bone sarcomas (BS) are performed in western countries, with few in the Middle East and North Africa region. We describe the epidemiology of sarcomas in Lebanon using the medical records database at the American University of Beirut Medical Center (AUBMC). Methods: This single-center retrospective cohort study included patients with sarcomas registered in the database between 2015 and 2019. Their charts were reviewed for baseline characteristics, tumor biology and location, treatment modalities, recurrence, metastasis, and death. Results: The cohort included 234 patients with STS and 99 patients with BS. Most tumors were <10 cm in size. The most common subtypes were liposarcoma for STS and osteosarcoma for BS. The most common location of STS was the thigh. The most frequent sites of STS metastasis were the lungs. Histological subtype, smoking status, and tumor size and grade were significant for progression-free survival (PFS) in patients with STS. By multivariable analysis, smoking was significantly associated with poorer PFS in STS. For BS, only tumor grade was significant for PFS. Conclusion: The epidemiology of sarcomas at AUBMC is similar to that previously reported. Smoking history was associated with poorer survival in patients with STS.